A mulit-centre, long term follow-up, open label trial to assess the efficacy and safety of Cpn10 in subjects with rheumatoid arthritis (Protocol number CBIO2008-01)
/ Active, not recruitingPhase 2 A multi-centre, randomised, double blind, placebo-controlled, parallel group, phase IIa clinical trial to assess the efficacy and safety of Cpn10 administered as twice weekly subcutaneous injections in subjects with Rheumatoid Arthritis
A multicentre, double blind, parallel group, phase IIa clinical trial to assess the efficacy and safety of Cpn10 administered as twice weekly intravenous injections in subjects with rheumatoid arthritis
100 Clinical Results associated with CBio Ltd.
0 Patents (Medical) associated with CBio Ltd.
100 Deals associated with CBio Ltd.
100 Translational Medicine associated with CBio Ltd.